Reversing the tide of COPD: smoking cessation

D. Sin

DOI: https://doi.org/10.1111/j.1752-699X.2007.00043.x

2008-01-01

Abstract:There are a more than a billion adults in the world who smoke (1). Sadly, a third of them will die from a tobacco-related complication. In 2000, approximately 4.8 million smokers died (prematurely) from a tobacco-related illness (2). If current smoking trends persist, smoking will kill over a billion people worldwide in this century (1). The main causes of death from tobacco smoking are predictable. Approximately 20% die from chronic obstructive pulmonary disease (COPD), another 17% die from lung cancer and a third succumb to cardiovascular diseases (2). Because COPD is an independent risk factor for both lung cancer and cardiovascular disease, it is directly or indirectly responsible for the vast majority of deaths in smokers (3,4). While these data are bleak, the good news is that with smoking cessation (and prevention) many of these premature deaths can be avoided. Friedman and Bloomberg estimate that if worldwide smoking rates decrease by just 5% (from the current 25%), 158 million deaths will be prevented in this century (1). There are other benefits to smoking cessation. A reduction in tobacco consumption in the population will lead to fewer cases of COPD and related complications, such as lung cancer and cardiovascular disease, almost immediately because smoking cessation causes a rapid improvement in lung function. In young people, smoking cessation leads to an 11 ml increase in forced expiratory volume in the first second (FEV1) annually compared with continued smoking (5). For older (40 to 70 years of age) individuals, smoking cessation results in even bigger improvements in FEV1: on average by 47 ml (or 2% of FEV1 as percent predicted) in the first year of smoking abstinence. By contrast, individuals who continue to smoke experience a 49 ml fall in FEV1 (6). Over 5 years, individuals who stop smoking experience a near normal decline in FEV1 (on average about 31 ml per year or 0.27 % predicted per year). However, individuals who continue to smoke experience a rapid loss in FEV1 (on average by 62 ml per year). Individuals who stop smoking but then take up the habit after a year of abstinence experience a 43 ml decrease in FEV1 per year (6). Smoking cessation also reduces the risk of COPD hospitalization by nearly a half (7) and the risk of lung cancer and cardiovascular mortality by over 50% in mild to moderate COPD patients (8). The benefits of smoking cessation are particularly notable in women, who experience larger gains in FEV1 following smoking cessation than do men (9). As discussed, the health benefits of smoking cessation are enormous. Yet, overwhelming evidence suggests that only a minority of health care professionals (and in particular clinicians) consistently offer advice regarding smoking cessation to their patients who smoke (10,11). In the July 2007 issue of The Clinical Respiratory Journal, Thy and colleagues explore the attitude of physicians working at a Norwegian hospital towards smoking cessation counseling to better understand potential barriers in promoting smoking abstinence by clinicians (12). The results are sobering. About a third of the respondents felt that offering advice on smoking cessation was too time-consuming, another third felt that it was not worth the effort, another third felt that it was not their job to offer smoking cessation counseling and about 25% indicated that they lacked sufficient knowledge to accomplish this task. Even when patients wanted to quit smoking, less than 7% of the respondents consistently provided written materials to help them quit. Less than 5% referred them to a smoking cessation class or clinic. These attitudes are shared by clinicians in other parts of the world (13,14). Despite the nihilistic attitude towards smoking cessation by many clinicians, their advice can make a difference, especially in a well-structured multidisciplinary setting. With intensive smoking cessation Requests: Don D. Sin James Hogg iCAPTURE Centre, St. Paul’s Hospital, Vancouver, BC. Canada V6Z 1Y6 Tel: 1-604-806-8395 Fax: 1-604-806-9274 Email: dsin@mrl.ubc.ca

Medicine